Business
Press Release Aug 17 2023
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 17, 2023, titled "Glenmark Pharmaceuticals receives sANDA approval for Tacrolimus Ointment, 0.03%".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 17, 2023, titled \"Glenmark Pharmaceuticals receives sANDA approval for Tacrolimus Ointment, 0.03%\". View Attachment","length":341,"tagName":"div"}]